Average Co-Inventor Count = 8.05
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Kansas (10 from 548 patents)
2. Amgen Inc. (8 from 1,975 patents)
3. The University of New Mexico (4 from 917 patents)
4. Southern Research Institute (4 from 203 patents)
5. University of Louisville Research Foundation (3 from 380 patents)
6. University of Michigan (2 from 3,384 patents)
7. Wayne State University (2 from 580 patents)
8. Sanford-Burnham Medical Research Institute (2 from 99 patents)
9. Yale University (1 from 1,327 patents)
10. Epix Pharmaceuticals, Inc. (1 from 14 patents)
20 patents:
1. 11219625 - Inhibitors of-linked glycosylation and methods using same
2. 10787439 - Compounds and methods for activating the apoptotic arm of the unfolded protein response
3. 10532999 - 6-substituted quinazolinone inhibitors
4. 10087168 - 6-substituted quinazolinone inhibitors
5. 9732067 - Compounds and methods for activating the apoptotic arm of the unfolded protein response
6. 9642835 - Modulators of GTPase and use in relevant treatment
7. 9580393 - 6-substituted quinazolinone inhibitors
8. 9499496 - Inhibitors of respiratory syncytial virus
9. 9376452 - Rab7 GTPase inhibitors and related methods of treatment
10. 9056111 - Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment
11. 8765803 - Rab7 GTPase inhibitors and related methods of treatment
12. 8097620 - Diazaquinolones that inhibit prolyl hydroxylase activity
13. 8048892 - Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
14. 8017626 - Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
15. 8012968 - Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof